Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Ardena, a fully integrated Contract Development and Manufacturing Organization (CDMO) assisting biopharma companies with services spanning all the development life cycle, has announced upgrades to its development and manufacturing facilities in ...
read more
CoreRx, Inc., a CDMO with formulation, development and GMP manufacturing sites in Clearwater, Florida and San Rafael, California, is pleased to announce the appointment of Sitakant (S.K.) Chaudhury as Chief Financial Officer and as a member of CoreRx...
read more
Hovione, a provider of spray drying and particle engineering services, announced an exclusive license agreement for a preclinical ophthalmology program, JX08, with Ji Xing Pharmaceuticals Limited (JIXING).
read more
Taiwan-based contract development and manufacturing organization (CDMO) Bora Pharmaceuticals has announced the establishment of Bora Biologics Co., Ltd., a CDMO platform for biologics.
read more
Genovac, a contract research and manufacturing organization (CRO/CMO) that discovers, develops, and manufactures antibodies for therapeutic, diagnostic and research market segments, and ENPICOM, a bioinformatics software engineering company, ...
read more
PCI Pharma Services (PCI), has announced a major expansion of capabilities and capacity in aseptic liquid fill-finish and sterile lyophilization technology, an important manufacturing process commonly used with injectable and biologic therapies, with...
read more
ALSA Ventures, a London based European biotech investment firm, and Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, announced a framework collaboration agreement to help ALSA’s portfolio of pre-...
read more
Certified proof of sustainability in the areas of environment, labor, ethics and procurement is becoming increasingly important for companies and their suppliers. Almost half of the world’s leading pharmaceutical companies use the EcoVadis assessment...
read more
Emmes – a global, full-service Contract Research Organization (CRO) will introduce to market its third generation version of Advantage eClinical at Society for Clinical Trials (SCT) in San Diego, May 15th – 18th.
read more
Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas such as oncology, central nervous system (CNS), and rare disease, has entered into an agreement to partner with N-SIDE — a deeptech ...
read more
Bristol Myers Squibb and LOTTE Corporation announced that LOTTE has agreed to purchase Bristol Myers Squibb’s manufacturing facility in East Syracuse, New York.
read more
Crown Bioscience and Medical & Biological Laboratories (MBL), JSR Life Sciences companies, announced the formation of a joint venture, to further expand the provision of Crown Bioscience’s preclinical services to Japanese customers.
read more
Crown Bioscience and Medical & Biological Laboratories (MBL), JSR Life Sciences companies announced the formation of a joint venture, to further expand the provision of Crown Bioscience’s preclinical services to Japanese customers.
read more
CoreRx, Inc., an industry-leading CDMO with formulation development, analytical services and GMP manufacturing sites in Clearwater, Florida and San Rafael, California announces Michael Grass, Ph.D. has joined CoreRx as Senior Director of Product ...
read more
Catalent has introduced its UpTempo Virtuoso™ platform process for the development and CGMP manufacturing of adeno-associated viral (AAV) vectors. The UpTempo Virtuoso platform standardizes and streamlines many time-consuming steps in AAV ...
read more